Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Joel Marrs

Concepts (184)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
7
2022
449
1.400
Why?
Antihypertensive Agents
5
2021
519
1.340
Why?
Hypertension
7
2021
1272
1.260
Why?
Pharmacists
8
2023
260
1.230
Why?
Hypolipidemic Agents
5
2026
89
1.070
Why?
Dyslipidemias
6
2026
184
1.060
Why?
Aspirin
3
2015
405
1.020
Why?
Text Messaging
3
2025
188
0.970
Why?
Platelet Aggregation Inhibitors
3
2015
499
0.960
Why?
Cardiovascular Diseases
10
2026
2219
0.940
Why?
Education, Pharmacy
6
2023
125
0.860
Why?
Diabetes Mellitus, Type 2
7
2017
2623
0.740
Why?
Anticoagulants
2
2019
746
0.700
Why?
Thiophenes
2
2015
117
0.680
Why?
Atrial Fibrillation
2
2019
560
0.670
Why?
Allylamine
2
2012
6
0.650
Why?
Stroke
4
2019
1287
0.640
Why?
Cardiovascular Agents
3
2026
165
0.550
Why?
Internship, Nonmedical
2
2010
10
0.550
Why?
Medication Reconciliation
1
2018
31
0.530
Why?
Practice Guidelines as Topic
6
2026
1591
0.450
Why?
Pharmaceutical Services
2
2020
76
0.440
Why?
Cholesterol, LDL
5
2019
363
0.440
Why?
Heart Failure, Diastolic
1
2015
23
0.430
Why?
Kidney Failure, Chronic
2
2011
589
0.430
Why?
Ticlopidine
1
2015
52
0.430
Why?
Drug-Eluting Stents
1
2015
88
0.420
Why?
Thromboembolism
1
2015
129
0.410
Why?
Medically Underserved Area
1
2015
102
0.410
Why?
Blood Pressure
3
2016
1765
0.370
Why?
Reminder Systems
2
2025
149
0.370
Why?
Cardiology
2
2026
363
0.370
Why?
Piperazines
1
2015
368
0.360
Why?
Hypoglycemic Agents
2
2012
1412
0.360
Why?
Guideline Adherence
1
2016
594
0.360
Why?
Glucosides
1
2012
56
0.350
Why?
Patient Discharge
2
2018
997
0.340
Why?
Urban Population
1
2015
497
0.340
Why?
Humans
48
2026
146342
0.340
Why?
Anticholesteremic Agents
2
2012
156
0.330
Why?
Thrombosis
1
2015
398
0.330
Why?
Venous Thromboembolism
1
2015
332
0.330
Why?
Spironolactone
1
2010
40
0.310
Why?
Mineralocorticoid Receptor Antagonists
1
2010
69
0.300
Why?
Preceptorship
1
2010
68
0.290
Why?
Administration, Oral
3
2019
872
0.290
Why?
Professional Role
3
2020
172
0.280
Why?
Students, Pharmacy
1
2010
96
0.280
Why?
Medication Therapy Management
2
2020
73
0.270
Why?
Schools, Pharmacy
3
2021
48
0.260
Why?
Drug Therapy, Combination
4
2016
1036
0.260
Why?
Medication Adherence
3
2025
535
0.250
Why?
Angiotensin-Converting Enzyme Inhibitors
3
2021
228
0.250
Why?
Benzodiazepines
1
2008
158
0.250
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2007
46
0.250
Why?
Angiotensin Receptor Antagonists
2
2021
115
0.240
Why?
Family Practice
2
2010
422
0.240
Why?
Insurance Coverage
1
2008
248
0.240
Why?
Renal Dialysis
1
2010
461
0.240
Why?
Hypnotics and Sedatives
1
2008
223
0.230
Why?
Certification
3
2013
118
0.230
Why?
Deprescriptions
1
2026
38
0.230
Why?
Sleep Initiation and Maintenance Disorders
1
2008
198
0.220
Why?
Polypharmacy
1
2026
94
0.220
Why?
Hospitalization
2
2015
2475
0.220
Why?
Aged
11
2025
26432
0.210
Why?
Heart Failure
1
2018
2329
0.210
Why?
Faculty
2
2017
152
0.200
Why?
Poverty
1
2008
530
0.200
Why?
Endocrinology
1
2025
77
0.200
Why?
Specialization
3
2013
137
0.180
Why?
Social Identification
1
2023
70
0.180
Why?
Ambulatory Care
1
2007
628
0.180
Why?
Pharmacy
1
2021
32
0.170
Why?
Middle Aged
11
2025
36619
0.170
Why?
Colesevelam Hydrochloride
2
2012
6
0.160
Why?
Pharmacy Service, Hospital
2
2013
90
0.160
Why?
Cell Phone
1
2021
83
0.160
Why?
American Heart Association
3
2026
364
0.160
Why?
Secondary Prevention
3
2016
248
0.150
Why?
Brain Ischemia
2
2013
362
0.140
Why?
Diabetes Mellitus
2
2020
1101
0.140
Why?
United States
11
2026
16136
0.140
Why?
Societies, Pharmaceutical
3
2021
14
0.140
Why?
Female
13
2025
79499
0.140
Why?
Software
1
2023
676
0.130
Why?
Age Factors
2
2016
3347
0.130
Why?
Heart Valve Diseases
1
2019
151
0.130
Why?
Retrospective Studies
6
2021
17438
0.130
Why?
Colorado
2
2023
4595
0.130
Why?
4-Hydroxycoumarins
1
2016
3
0.120
Why?
Blood Glucose
3
2012
2360
0.120
Why?
Vitamin K
1
2016
46
0.120
Why?
Dissociative Disorders
1
2016
30
0.120
Why?
Cholesterol
3
2019
411
0.120
Why?
Community Participation
1
2017
128
0.120
Why?
Clinical Trials as Topic
2
2012
1064
0.120
Why?
Male
11
2025
73396
0.120
Why?
Primary Prevention
2
2014
222
0.110
Why?
Risk Factors
5
2019
10921
0.110
Why?
Aged, 80 and over
4
2015
8391
0.110
Why?
Patient Transfer
1
2018
224
0.110
Why?
Guidelines as Topic
1
2016
267
0.100
Why?
Blood Coagulation Disorders
1
2016
190
0.100
Why?
Diuretics
2
2011
66
0.100
Why?
Adult
8
2025
41087
0.100
Why?
Telemedicine
1
2022
966
0.100
Why?
Emotional Intelligence
2
2023
13
0.090
Why?
Suicide, Attempted
1
2016
391
0.090
Why?
Follow-Up Studies
3
2016
5439
0.090
Why?
Treatment Outcome
2
2019
11821
0.090
Why?
Acute Disease
1
2015
1038
0.090
Why?
Data Collection
1
2014
650
0.090
Why?
Atherosclerosis
1
2015
410
0.090
Why?
Benzhydryl Compounds
1
2012
81
0.080
Why?
Hyperlipidemias
1
2012
120
0.080
Why?
Health Promotion
1
2017
786
0.080
Why?
Continuity of Patient Care
1
2013
298
0.080
Why?
Universities
1
2013
451
0.080
Why?
Sex Factors
1
2016
2107
0.080
Why?
Drug Resistance
1
2010
145
0.080
Why?
Interinstitutional Relations
1
2010
56
0.080
Why?
Cross-Sectional Studies
1
2021
5899
0.070
Why?
Pragmatic Clinical Trials as Topic
2
2021
135
0.070
Why?
Myocardial Infarction
1
2016
1215
0.070
Why?
Coronary Artery Disease
1
2015
751
0.070
Why?
Pregnancy
1
2021
7230
0.070
Why?
Advisory Committees
2
2021
228
0.070
Why?
Patient-Centered Care
1
2013
553
0.070
Why?
Dipeptidyl Peptidase 4
1
2007
15
0.060
Why?
Adamantane
1
2007
18
0.060
Why?
Emotions
2
2023
559
0.060
Why?
Receptors, GABA-A
1
2008
138
0.060
Why?
Drug Monitoring
1
2010
399
0.060
Why?
Eicosapentaenoic Acid
1
2006
37
0.060
Why?
Hypertriglyceridemia
1
2006
45
0.060
Why?
Pyrrolidines
1
2007
127
0.060
Why?
Practice Patterns, Physicians'
1
2015
1408
0.060
Why?
Docosahexaenoic Acids
1
2006
91
0.060
Why?
Nitriles
1
2007
212
0.060
Why?
Inappropriate Prescribing
1
2026
68
0.060
Why?
Exercise
1
2017
2213
0.060
Why?
Aging
1
2016
1996
0.060
Why?
Fatty Acids, Omega-3
1
2006
145
0.050
Why?
Risk Assessment
2
2016
3712
0.050
Why?
Insurance, Health
1
2008
318
0.050
Why?
Young Adult
4
2015
14330
0.050
Why?
Hyperglycemia
1
2009
384
0.050
Why?
Triglycerides
1
2006
527
0.050
Why?
Patient Compliance
1
2008
589
0.050
Why?
Enzyme Inhibitors
1
2007
823
0.050
Why?
Animals
3
2012
38107
0.050
Why?
Pandemics
2
2022
1707
0.050
Why?
Adolescent
4
2015
22557
0.050
Why?
Sleep
1
2008
896
0.040
Why?
Curriculum
1
2006
1079
0.040
Why?
Annual Reports as Topic
1
2017
2
0.030
Why?
Students
1
2023
649
0.030
Why?
Lipids
1
2022
714
0.030
Why?
Organizational Policy
1
2017
76
0.030
Why?
Health Personnel
1
2021
754
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1763
0.030
Why?
Eating
1
2016
386
0.020
Why?
Mechanical Thrombolysis
1
2013
5
0.020
Why?
Telephone
1
2013
175
0.020
Why?
Adrenergic Antagonists
1
2011
5
0.020
Why?
Clinical Competence
2
2011
1272
0.020
Why?
Thrombolytic Therapy
1
2013
165
0.020
Why?
Angiotensin II Type 1 Receptor Blockers
1
2011
39
0.020
Why?
Phytotherapy
1
2011
74
0.020
Why?
Calcium Channel Blockers
1
2011
165
0.020
Why?
Drug Utilization
1
2011
171
0.020
Why?
Patient Care Management
1
2010
54
0.020
Why?
Hospitals, University
1
2010
178
0.020
Why?
Cohort Studies
1
2020
6077
0.020
Why?
Governing Board
1
2009
7
0.020
Why?
Prospective Studies
1
2020
8123
0.020
Why?
Patient Readmission
1
2013
778
0.020
Why?
Length of Stay
1
2013
1358
0.020
Why?
Databases, Factual
1
2013
1493
0.020
Why?
Inpatients
1
2010
540
0.010
Why?
Prevalence
1
2013
2861
0.010
Why?
Drug Combinations
1
2006
400
0.010
Why?
Primary Health Care
1
2015
1776
0.010
Why?
Marrs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)